SafeHeal (@safeheal) 's Twitter Profile
SafeHeal

@safeheal

ID: 4878055828

calendar_today05-02-2016 15:21:56

50 Tweet

59 Takipçi

312 Takip Edilen

SafeHeal (@safeheal) 's Twitter Profile Photo

Congratulations Weill Cornell Medicine Surgery/NewYork-Presbyterian for your first enrolled patient in the SafeHeal SOC23 trial! We are so excited and honored to be aligned with you. Dorna Jafari, MD, FACS, FASCRS #colorectalanastomosisprotection safeheal.com

SafeHeal (@safeheal) 's Twitter Profile Photo

Honored to be working with John Marks and Henry Schoonyoung, MD, FACS Main Line Health (Lankenau Hospital) as we seek an alternative to temporary diverting stoma. #RectalCancer . Visit Safeheal.com to learn more/participate in our study

SafeHeal (@safeheal) 's Twitter Profile Photo

Welcome David Hiller and his team Novant Health to the SafeHeal SOC trial. If you or someone you know must undergo #rectalcancer surgery w/diverting ostomy please reach out him to see if you are eligible for our clinical trial. Visit safeheal.com for information

SafeHeal (@safeheal) 's Twitter Profile Photo

We’re proud to announce the successful completion of enrollment in our Standard of Care (SH-SOC23) arm, the first phase of our two-part study in rectal cancer surgery! 🚀 🔜 Next Up: Once IDE approval is obtained, SafeHeal will initiate the SAFE-3CV study, which will evaluate

We’re proud to announce the successful completion of enrollment in our Standard of Care (SH-SOC23) arm, the first phase of our two-part study in rectal cancer surgery! 🚀

🔜 Next Up: Once IDE approval is obtained, SafeHeal will initiate the SAFE-3CV study, which will evaluate
SafeHeal (@safeheal) 's Twitter Profile Photo

🎉 Exciting News! 🎉 SafeHeal® recently closed an oversubscribed €35 million Series C equity financing, led by Solar Eclipse with new investors Gideon Strategic Partners and M&L Healthcare (part of M&L Group), and continued support from Sofinnova Partners and a leading

SafeHeal (@safeheal) 's Twitter Profile Photo

The milestone needed to achieve to raise Series A capital seems to have shifted to proof-of-concept to first-in-man for many VCs...tricky !

SafeHeal (@safeheal) 's Twitter Profile Photo

The milestone needed to raise Series A capital seems to have shifted to proof-of-concept to first-in-man for many VCs... #MedTechInnovator

SafeHeal (@safeheal) 's Twitter Profile Photo

A4 : Derisk your regulatory pathway early in your development, with CE clinical pathway review with NB and FDA pre-sub #MedTechInnovator

SafeHeal (@safeheal) 's Twitter Profile Photo

A6 : EU notified bodies are extremely late in delivering their reports due to excessive workload after the CE mark changes #MedTechInnovator

SafeHeal (@safeheal) 's Twitter Profile Photo

A8 : not really if you're providing a disruptive approach / product... but people might shy away due to the risk profile #MedTechInnovator

SafeHeal (@safeheal) 's Twitter Profile Photo

#safeheal Avoid the delibitation of ostomies and the need for the ostomy takedown surgery - a huge win for patients ! #medtechinnovator